Quick Order Cart

Cat. No. ARG32669

IMPACT Knockout SK-HEP-1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Liver

  • Disease:

    Adenocarcinoma

This CRISPR/Cas9-edited polyclonal knockout cell population of the SK-HEP-1 human liver adenocarcinoma cell line features targeted disruption of the IMPACT gene, which encodes an inhibitor of GCN2 kinase that negatively regulates the integrated stress response (ISR) by binding GCN1 and suppressing eIF2?? phosphorylation and ATF4 translation. The knockout provides a loss-of-function model for dissecting ISR signaling, translational control, and amino acid sensing pathways. With its dual hepatocellular carcinoma and endothelial-like background, these cells are ideal for investigating nutrient stress adaptation, hepatocellular carcinoma biology, and for screening small-molecule modulators of the GCN2?CeIF2???CATF4 axis using functional assays such as phospho-eIF2?? western blotting, ATF4 luciferase reporter, and cell viability under metabolic stress.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    SK-HEP-1

    Sex of Donor

    Male

    Age

    52 years

    Gene Name

    IMPACT

    Gene Identifier

    NCBI Gene ID 55364

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    MEM (with NEAA)

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The IMPACT Knockout SK-HEP-1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the SK-HEP-1 human liver adenocarcinoma cell line, featuring targeted disruption of the IMPACT gene (also known as Imprinted and Ancient Gene Protein). This pooled population provides a loss-of-function model to study the role of IMPACT in translational control and the integrated stress response.

SK-HEP-1 cells were originally isolated from the ascites of a patient with liver adenocarcinoma and exhibit an adherent, aneuploid phenotype with notable endothelial-like characteristics, making them a valuable dual model for hepatocellular carcinoma (HCC) biology and liver endothelial cell function.

IMPACT functions as a negative regulator of the integrated stress response (ISR) by binding GCN1 and preventing GCN2 kinase-mediated phosphorylation of the eukaryotic translation initiation factor 2?? (eIF2??). Under amino acid deprivation, IMPACT acts downstream of mTORC1 signaling and upstream of GCN2, eIF2?? phosphorylation, and ATF4 transcription. IMPACT physically interacts with GCN1, GCN2, and the ribosome, and its disruption releases GCN2-dependent signaling, leading to increased eIF2?? phosphorylation, ATF4 translation, and expression of downstream effectors such as CHOP and GADD34, ultimately suppressing global protein synthesis.

In the SK-HEP-1 background, knockout of IMPACT provides a physiologically relevant system to interrogate how deregulated ISR contributes to hepatocellular carcinoma progression and the endothelial-like behavior of these tumor cells. The model enables dissection of amino acid sensing and translational reprogramming in the context of liver cancer cell survival, proliferation, and metabolic adaptation under nutrient-limited conditions typically encountered in solid tumors.

These polyclonal knockout cells are suitable for a range of functional assays, including western blotting for phospho-eIF2?? and ATF4, luciferase reporter assays for ISR activity, RT-qPCR profiling of ATF4/CHOP/GADD34 induction under amino acid starvation, co-immunoprecipitation of IMPACT-GCN1 complexes (in wild-type controls), cell viability measurements under nutrient stress, and puromycin incorporation assays to monitor translational output. They serve as a robust platform for studying integrated stress response signaling, translational control in cancer, and for screening small molecules that modulate the GCN2?CeIF2???CATF4 axis. For additional details, technical support, or custom cell engineering services, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)